The Dixie Group, Inc. (DXYN) Stock Competitors & Peer Comparison
See (DXYN) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DXYN | $0.40 | -4.76% | 5.6M | -1.33 | -$0.30 | N/A |
| RL | $366.55 | -0.05% | 22.3B | 24.26 | $15.10 | +1.00% |
| LEVI | $22.53 | +0.00% | 8.9B | 16.56 | $1.36 | +2.50% |
| GIL | $57.61 | -0.45% | 8.8B | 33.69 | $1.71 | +1.65% |
| VFC | $16.59 | +0.48% | 6.5B | 25.91 | $0.64 | +2.19% |
| ZGN | $14.65 | -1.81% | 3.9B | 33.32 | $0.44 | +0.97% |
| KTB | $70.07 | +2.07% | 3.9B | 14.13 | $4.96 | +3.01% |
| PVH | $77.80 | -0.46% | 3.6B | 23.56 | $3.30 | +0.20% |
| COLM | $64.22 | -1.03% | 3.3B | 20.52 | $3.13 | +1.88% |
| UAA | $5.56 | -0.36% | 2.4B | -4.79 | -$1.16 | N/A |
Stock Comparison
DXYN vs RL Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, RL has a market cap of 22.3B. Regarding current trading prices, DXYN is priced at $0.40, while RL trades at $366.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas RL's P/E ratio is 24.26. In terms of profitability, DXYN's ROE is -0.41%, compared to RL's ROE of +0.35%. Regarding short-term risk, DXYN is less volatile compared to RL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check RL's competition here
DXYN vs LEVI Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, LEVI has a market cap of 8.9B. Regarding current trading prices, DXYN is priced at $0.40, while LEVI trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas LEVI's P/E ratio is 16.56. In terms of profitability, DXYN's ROE is -0.41%, compared to LEVI's ROE of +0.28%. Regarding short-term risk, DXYN is less volatile compared to LEVI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LEVI's competition here
DXYN vs GIL Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, GIL has a market cap of 8.8B. Regarding current trading prices, DXYN is priced at $0.40, while GIL trades at $57.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas GIL's P/E ratio is 33.69. In terms of profitability, DXYN's ROE is -0.41%, compared to GIL's ROE of +0.10%. Regarding short-term risk, DXYN is less volatile compared to GIL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIL's competition here
DXYN vs VFC Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, VFC has a market cap of 6.5B. Regarding current trading prices, DXYN is priced at $0.40, while VFC trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas VFC's P/E ratio is 25.91. In terms of profitability, DXYN's ROE is -0.41%, compared to VFC's ROE of +0.16%. Regarding short-term risk, DXYN is less volatile compared to VFC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VFC's competition here
DXYN vs ZGN Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, ZGN has a market cap of 3.9B. Regarding current trading prices, DXYN is priced at $0.40, while ZGN trades at $14.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas ZGN's P/E ratio is 33.32. In terms of profitability, DXYN's ROE is -0.41%, compared to ZGN's ROE of +0.10%. Regarding short-term risk, DXYN is less volatile compared to ZGN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check ZGN's competition here
DXYN vs KTB Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, KTB has a market cap of 3.9B. Regarding current trading prices, DXYN is priced at $0.40, while KTB trades at $70.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas KTB's P/E ratio is 14.13. In terms of profitability, DXYN's ROE is -0.41%, compared to KTB's ROE of +0.50%. Regarding short-term risk, DXYN is less volatile compared to KTB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KTB's competition here
DXYN vs PVH Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, PVH has a market cap of 3.6B. Regarding current trading prices, DXYN is priced at $0.40, while PVH trades at $77.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas PVH's P/E ratio is 23.56. In terms of profitability, DXYN's ROE is -0.41%, compared to PVH's ROE of +0.03%. Regarding short-term risk, DXYN is less volatile compared to PVH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PVH's competition here
DXYN vs COLM Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, COLM has a market cap of 3.3B. Regarding current trading prices, DXYN is priced at $0.40, while COLM trades at $64.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas COLM's P/E ratio is 20.52. In terms of profitability, DXYN's ROE is -0.41%, compared to COLM's ROE of +0.10%. Regarding short-term risk, DXYN is less volatile compared to COLM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check COLM's competition here
DXYN vs UAA Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, UAA has a market cap of 2.4B. Regarding current trading prices, DXYN is priced at $0.40, while UAA trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas UAA's P/E ratio is -4.79. In terms of profitability, DXYN's ROE is -0.41%, compared to UAA's ROE of -0.30%. Regarding short-term risk, DXYN is less volatile compared to UAA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UAA's competition here
DXYN vs UA Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, UA has a market cap of 2.3B. Regarding current trading prices, DXYN is priced at $0.40, while UA trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas UA's P/E ratio is -4.64. In terms of profitability, DXYN's ROE is -0.41%, compared to UA's ROE of -0.30%. Regarding short-term risk, DXYN is less volatile compared to UA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UA's competition here
DXYN vs HBI Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, HBI has a market cap of 2.3B. Regarding current trading prices, DXYN is priced at $0.40, while HBI trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas HBI's P/E ratio is 5.53. In terms of profitability, DXYN's ROE is -0.41%, compared to HBI's ROE of +1.91%. Regarding short-term risk, DXYN is less volatile compared to HBI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check HBI's competition here
DXYN vs FIGS Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, FIGS has a market cap of 2B. Regarding current trading prices, DXYN is priced at $0.40, while FIGS trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas FIGS's P/E ratio is 53.98. In terms of profitability, DXYN's ROE is -0.41%, compared to FIGS's ROE of +0.10%. Regarding short-term risk, DXYN is less volatile compared to FIGS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check FIGS's competition here
DXYN vs AIN Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, AIN has a market cap of 1.9B. Regarding current trading prices, DXYN is priced at $0.40, while AIN trades at $67.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas AIN's P/E ratio is -34.59. In terms of profitability, DXYN's ROE is -0.41%, compared to AIN's ROE of -0.08%. Regarding short-term risk, DXYN is less volatile compared to AIN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check AIN's competition here
DXYN vs GIII Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, GIII has a market cap of 1.4B. Regarding current trading prices, DXYN is priced at $0.40, while GIII trades at $33.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas GIII's P/E ratio is 22.32. In terms of profitability, DXYN's ROE is -0.41%, compared to GIII's ROE of +0.07%. Regarding short-term risk, DXYN is less volatile compared to GIII. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIII's competition here
DXYN vs GOOS Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, GOOS has a market cap of 949.2M. Regarding current trading prices, DXYN is priced at $0.40, while GOOS trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas GOOS's P/E ratio is 57.53. In terms of profitability, DXYN's ROE is -0.41%, compared to GOOS's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to GOOS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GOOS's competition here
DXYN vs OXM Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, OXM has a market cap of 656.7M. Regarding current trading prices, DXYN is priced at $0.40, while OXM trades at $44.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas OXM's P/E ratio is -23.69. In terms of profitability, DXYN's ROE is -0.41%, compared to OXM's ROE of -0.05%. Regarding short-term risk, DXYN is less volatile compared to OXM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check OXM's competition here
DXYN vs SGC Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, SGC has a market cap of 200.4M. Regarding current trading prices, DXYN is priced at $0.40, while SGC trades at $12.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas SGC's P/E ratio is 22.49. In terms of profitability, DXYN's ROE is -0.41%, compared to SGC's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to SGC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SGC's competition here
DXYN vs LAKE Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, LAKE has a market cap of 91.5M. Regarding current trading prices, DXYN is priced at $0.40, while LAKE trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas LAKE's P/E ratio is -3.53. In terms of profitability, DXYN's ROE is -0.41%, compared to LAKE's ROE of -0.18%. Regarding short-term risk, DXYN is less volatile compared to LAKE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LAKE's competition here
DXYN vs UFI Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, UFI has a market cap of 76.8M. Regarding current trading prices, DXYN is priced at $0.40, while UFI trades at $4.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas UFI's P/E ratio is -9.83. In terms of profitability, DXYN's ROE is -0.41%, compared to UFI's ROE of -0.17%. Regarding short-term risk, DXYN is less volatile compared to UFI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UFI's competition here
DXYN vs FFFZ Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, FFFZ has a market cap of 68.8M. Regarding current trading prices, DXYN is priced at $0.40, while FFFZ trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas FFFZ's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.41%, compared to FFFZ's ROE of N/A. Regarding short-term risk, DXYN and FFFZ have similar daily volatility (0.00).Check FFFZ's competition here
DXYN vs VNCE Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, VNCE has a market cap of 57M. Regarding current trading prices, DXYN is priced at $0.40, while VNCE trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas VNCE's P/E ratio is 9.06. In terms of profitability, DXYN's ROE is -0.41%, compared to VNCE's ROE of +0.13%. Regarding short-term risk, DXYN is less volatile compared to VNCE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VNCE's competition here
DXYN vs JRSH Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, JRSH has a market cap of 43.4M. Regarding current trading prices, DXYN is priced at $0.40, while JRSH trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas JRSH's P/E ratio is 24.43. In terms of profitability, DXYN's ROE is -0.41%, compared to JRSH's ROE of +0.03%. Regarding short-term risk, DXYN is less volatile compared to JRSH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JRSH's competition here
DXYN vs CULP Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, CULP has a market cap of 40M. Regarding current trading prices, DXYN is priced at $0.40, while CULP trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas CULP's P/E ratio is -3.95. In terms of profitability, DXYN's ROE is -0.41%, compared to CULP's ROE of -0.13%. Regarding short-term risk, DXYN is less volatile compared to CULP. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check CULP's competition here
DXYN vs JL Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, JL has a market cap of 23.2M. Regarding current trading prices, DXYN is priced at $0.40, while JL trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas JL's P/E ratio is 9.06. In terms of profitability, DXYN's ROE is -0.41%, compared to JL's ROE of +0.31%. Regarding short-term risk, DXYN is less volatile compared to JL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JL's competition here
DXYN vs LLL Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, LLL has a market cap of 10.8M. Regarding current trading prices, DXYN is priced at $0.40, while LLL trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas LLL's P/E ratio is -0.10. In terms of profitability, DXYN's ROE is -0.41%, compared to LLL's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to LLL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LLL's competition here
DXYN vs XELB Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, XELB has a market cap of 9.7M. Regarding current trading prices, DXYN is priced at $0.40, while XELB trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas XELB's P/E ratio is -0.47. In terms of profitability, DXYN's ROE is -0.41%, compared to XELB's ROE of -0.90%. Regarding short-term risk, DXYN is less volatile compared to XELB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check XELB's competition here
DXYN vs PMNT Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, PMNT has a market cap of 7.5M. Regarding current trading prices, DXYN is priced at $0.40, while PMNT trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas PMNT's P/E ratio is -0.32. In terms of profitability, DXYN's ROE is -0.41%, compared to PMNT's ROE of -10.56%. Regarding short-term risk, DXYN is less volatile compared to PMNT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PMNT's competition here
DXYN vs NCI Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, NCI has a market cap of 5.2M. Regarding current trading prices, DXYN is priced at $0.40, while NCI trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas NCI's P/E ratio is 128.13. In terms of profitability, DXYN's ROE is -0.41%, compared to NCI's ROE of +0.01%. Regarding short-term risk, DXYN is less volatile compared to NCI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check NCI's competition here
DXYN vs JXJT Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, JXJT has a market cap of 4.9M. Regarding current trading prices, DXYN is priced at $0.40, while JXJT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas JXJT's P/E ratio is 1.47. In terms of profitability, DXYN's ROE is -0.41%, compared to JXJT's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to JXJT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JXJT's competition here
DXYN vs DLA Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, DLA has a market cap of 4.1M. Regarding current trading prices, DXYN is priced at $0.40, while DLA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas DLA's P/E ratio is -0.06. In terms of profitability, DXYN's ROE is -0.41%, compared to DLA's ROE of -0.20%. Regarding short-term risk, DXYN is less volatile compared to DLA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check DLA's competition here
DXYN vs SQBG Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, SQBG has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.40, while SQBG trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas SQBG's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.41%, compared to SQBG's ROE of -1.42%. Regarding short-term risk, DXYN is less volatile compared to SQBG. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SQBG's competition here
DXYN vs EVK Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, EVK has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.40, while EVK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas EVK's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.41%, compared to EVK's ROE of -0.00%. Regarding short-term risk, DXYN is less volatile compared to EVK. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check EVK's competition here
DXYN vs PERY Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, PERY has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.40, while PERY trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas PERY's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.41%, compared to PERY's ROE of +0.15%. Regarding short-term risk, DXYN and PERY have similar daily volatility (0.00).Check PERY's competition here
DXYN vs KBSF Comparison June 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 5.6M. In comparison, KBSF has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.40, while KBSF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -1.33, whereas KBSF's P/E ratio is -1.46. In terms of profitability, DXYN's ROE is -0.41%, compared to KBSF's ROE of -0.10%. Regarding short-term risk, DXYN is less volatile compared to KBSF. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KBSF's competition here